Author Correction: A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activation

Affiliations

Sohaib Nizami: Alzheimer’s Research UK Oxford Drug Discovery Institute, NDM Research Building, University of Oxford, Old Road Campus
Val Millar: Alzheimer’s Research UK Oxford Drug Discovery Institute, NDM Research Building, University of Oxford, Old Road Campus
Kanisa Arunasalam: Alzheimer’s Research UK Oxford Drug Discovery Institute, NDM Research Building, University of Oxford, Old Road Campus
Tryfon Zarganes-Tzitzikas: Alzheimer’s Research UK Oxford Drug Discovery Institute, NDM Research Building, University of Oxford, Old Road Campus
David Brough: Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester
Gary Tresadern: Janssen Research and Development
Paul E. Brennan: Alzheimer’s Research UK Oxford Drug Discovery Institute, NDM Research Building, University of Oxford, Old Road Campus
John B. Davis: Alzheimer’s Research UK Oxford Drug Discovery Institute, NDM Research Building, University of Oxford, Old Road Campus
Daniel Ebner: Target Discovery Institute, NDM Research Building, University of Oxford, Old Road Campus
Elena Di Daniel: Alzheimer’s Research UK Oxford Drug Discovery Institute, NDM Research Building, University of Oxford, Old Road Campus

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.